Skip to main content
. 2020 May 15;7:32. doi: 10.1186/s40658-020-00303-0

Fig. 1.

Fig. 1

Dead time and renal dosimetry in personalized PRRT. The dead-time count loss affecting day 1 (a) and day 3 (b) QSPECT scans, the renal absorbed dose (c) and its deviation without dead-time correction (d) are plotted against the injected activity